The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer (SCLC) whose disease did not progress after concurrent platinum-based chemotherapy and radiation therapy.

The Queen’s Advanced Lung Institute will feature a team of expert health care providers focused on providing high quality care and early diagnosis of lung cancer for patients.

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research. This optimism comes in the wake of the Food and Drug Administration’s (FDA’s) approval of Imdelltra (tarlatamab-dlle) in May 2024 for the treatment of patients with extensive-stage small cell lung cancer (SCLC).

Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former smokers to strengthen lung health.

Discover essential steps to protect and strengthen your lungs, from quitting smoking to breathing exercises that can dramatically improve respiratory health.

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung cancer and better monitoring of treatment.

Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more recent diagnosis and prior glucocorticoid/steroid use.

The Republican House majority is in jeopardy due to the upcoming Supreme Court race in Wisconsin, which could result in a liberal majority on the court and the potential striking down of the state’s congressional map, costing Republicans two U.S. House seats.

Thousands of patients with lung cancer face delays in genomic testing, preventing timely access to targeted treatments that could improve survival rates, according to a report.

The first pilot screening programme of its kind for lung cancer has been announced for the communities of North Dublin and the North East, using mobile scanning units.

Up to 100 high-risk people may have lung cancer detected as part of a mobile screening initiative targeted at north Dublin and the north-east.